QICPCR Trademark

Trademark Overview


On Thursday, December 24, 2015, a trademark application was filed for QICPCR with the United States Patent and Trademark Office. The USPTO has given the QICPCR trademark a serial number of 79184304. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, September 22, 2023. This trademark is owned by HVIVO SERVICES LIMITED. The QICPCR trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, and Computer & Software Services & Scientific Services categories with the following description:

Biological laboratory preparations for medical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; viruses for medical purposes, namely, viruses for use as an ingredient in vaccines for preventing and treatment of influenza or HRV or RSV; biopharmaceutical preparations for the prevention, diagnosis, and treatment of influenza or HRV or RSV; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes; medical diagnostic reagents for the testing of body fluids; in-vivo diagnostic reagents for medical purposes

Maintenance of data in computer databases relating to individuals who have been tested for diagnostic purposes; product demonstration services in the field of diagnostic testing; computer database management services, namely, information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical and hospital records; providing referrals in the field of medical and scientific professionals; compilation of information into computer databases, namely, results from medical diagnostic testing; compilation of information into computer databases, namely, information regarding pharmaceutical testing procedures; compilation of information into computer databases, namely, information regarding diseases and disease prevention; compilation of information in...

Medical research laboratory services; conducting clinical trials for others in the field of influenza or HRV or RSV; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; scientific study and research in the field of infectious and chronic diseases and the treatment of influenza, common cold, RSV, COPD, asthma, diabetes, obesity; medical research into the causes and treatment of influenza and the common cold
qicpcr

General Information


Serial Number79184304
Word MarkQICPCR
Filing DateThursday, December 24, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, September 22, 2023
Registration Number5153196
Registration DateTuesday, March 7, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2016

Trademark Statements


Goods and ServicesBiological laboratory preparations for medical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical preparations and reagents for medical, pharmaceutical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; viruses for medical purposes, namely, viruses for use as an ingredient in vaccines for preventing and treatment of influenza or HRV or RSV; biopharmaceutical preparations for the prevention, diagnosis, and treatment of influenza or HRV or RSV; diagnostic preparations for medical and veterinary use; diagnostic preparations for medical purposes; medical diagnostic reagents for the testing of body fluids; in-vivo diagnostic reagents for medical purposes
Goods and ServicesMaintenance of data in computer databases relating to individuals who have been tested for diagnostic purposes; product demonstration services in the field of diagnostic testing; computer database management services, namely, information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical and hospital records; providing referrals in the field of medical and scientific professionals; compilation of information into computer databases, namely, results from medical diagnostic testing; compilation of information into computer databases, namely, information regarding pharmaceutical testing procedures; compilation of information into computer databases, namely, information regarding diseases and disease prevention; compilation of information into computer databases, namely, information regarding medical, hospital, insurance or billing records
Goods and ServicesMedical research laboratory services; conducting clinical trials for others in the field of influenza or HRV or RSV; medical research laboratory services for the analysis of samples taken from patients; scientific analysis and research services; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; scientific study and research in the field of infectious and chronic diseases and the treatment of influenza, common cold, RSV, COPD, asthma, diabetes, obesity; medical research into the causes and treatment of influenza and the common cold

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHVIVO SERVICES LIMITED
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLondon E1 2AX
GB

Party NameHVIVO SERVICES LIMITED
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon E1 2AX
GB

Party NameHVIVO SERVICES LIMITED
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLondon E1 2AX
GB

Trademark Events


Event DateEvent Description
Monday, September 26, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 10, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, March 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 18, 2016APPLICATION FILING RECEIPT MAILED
Monday, April 11, 2016ASSIGNED TO EXAMINER
Monday, April 18, 2016NON-FINAL ACTION WRITTEN
Tuesday, April 19, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 20, 2016REFUSAL PROCESSED BY MPU
Wednesday, April 20, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, May 14, 2016REFUSAL PROCESSED BY IB
Monday, September 26, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 27, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 30, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 26, 2016FINAL REFUSAL WRITTEN
Wednesday, October 26, 2016FINAL REFUSAL E-MAILED
Wednesday, October 26, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, November 10, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, November 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, November 11, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, November 11, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, December 20, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, June 7, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, June 19, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, July 8, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, May 9, 2019NEW REPRESENTATIVE AT IB RECEIVED
Wednesday, November 30, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, December 17, 2016NOTIFICATION PROCESSED BY IB
Tuesday, December 20, 2016PUBLISHED FOR OPPOSITION
Monday, June 19, 2017FINAL DISPOSITION PROCESSED
Monday, March 7, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 14, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, June 24, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, July 14, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Monday, June 24, 2024INVALIDATION PROCESSED
Friday, September 22, 2023CANCELLED SECTION 71